IQVIA Holdings | IQV - Equity Capital And Reserves


IQVIA Holdings reported $6.17B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Accenture USD 31.89B 679.89M Mar/2026
Agilent USD 7.12B 214M Mar/2026
Bruker USD 2.44B 67M Jun/2026
Cardinal Health USD -2.88B 51M Jun/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Cigna USD 42.62B 410M Jun/2026
Cognizant Technology Solutions USD 14.46B 606M Jun/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
CVS Health USD 79.7B 2.25B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Elevance Health USD 44.88B 981M Jun/2026
Humana USD 19.21B 633M Jun/2026
IBM USD 34.45B 1.48B Jun/2026
Illumina USD 2.84B 162M Jun/2026
Infosys INR -2.97B 833.23B Mar/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Laboratory Of America USD 8.61B 121.8M Jun/2026
Malin Corporation EUR 193.2M 75M Dec/2024
McKesson USD -4.24B 2.07B Jun/2026
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Pharma Mar EUR 250.77M 1.1M Jun/2026
Publicis EUR 10.52B 72M Jun/2026
Qiagen NV USD 3.36B 26.03M Jun/2026
Quest Diagnostics USD 7.52B 150M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
UnitedHealth USD 105.32B 3.62B Mar/2026
Veeva Systems USD 7.3B 89.6M Mar/2026
Veradigm USD 1.02B 159.52M Dec/2022
Waters USD 15.29B 12.73B Mar/2026
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026